Inclusion of "pharmacist" on OTC label warnings supported by majority of cmte. members.

Executive Summary

"PHARMACIST" INCLUSION IN OTC LABEL WARNINGS endorsed by a majority of the members of FDA's Nonprescription Drugs Advisory Committee at a July 14 meeting in Bethesda, Md. Asked by the agency to discuss possible alternatives to the "Ask a Doctor Before Use" phrase suggested in FDA's proposed rule on OTC label reform, the committee members recommended a number of possible options, with "pharmacist" and "health care professional" receiving the most support. The group did not vote on the issue; NDAC Chairman Ralph D'Agostino, PhD, Boston University, instead polled individual members for their preferences.